Fact CheckerSign in

NCT03997110Recruiting

Palliative Radiation for Advanced Cervical Cancer

Rapid Palliation in Locally Advanced Cervical Cancer: A Phase III Randomized Trial

Source: ClinicalTrials.gov · Last updated 17 Feb 2026

Brief summary (registry, in English)

The present study is proposed to compare a rapid fractionation schedule of 1 week compared to a protracted schedule of 6-8 weeks for palliation for locally advanced cervical cancer.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
230 (estimated)
First submitted
9 Apr 2019
Start date
19 Jun 2020
Primary completion date
1 Jul 2026
Lead sponsor
Tata Memorial Hospital
NCT number
NCT03997110

What you commit to

  • Study type: Interventional
  • Planned participants: 230
  • From 19 Jun 2020 to the primary completion date, 1 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with distant metastasis needing upfront systemic therapy.

Other illness

  • Presence of retroviral disease

Other

  • Non-compliant for follow up.
  • Expected survival \<3 months.

Who the study is looking for

  • Locally advanced cervical cancer (Stage IIIB-IVA) deemed unsuitable for full course radical pelvic radiotherapy or chemoradiation due to the following reasons:
    • Very large volume hard fixed disease infiltrating pelvic wall muscles and ligaments on clinical examination also classified clinically as "frozen pelvis" wherein curative intent treatment is not envisaged or feasible.
    • Fistulous communication between tumour growth and rectum and bladder \>2x2 cm in size (as judged by cystoscopy for bladder infiltration or clinical or proctosigmoidoscopy examination for rectal/sigmoid infiltration) wherein radical intent treatment is not intended or feasible and patient is not a candidate for pelvic exenteration.
    • Deranged renal parameters as measured by Serum Creatinine \>3 mg/dl wherein diversion nephrostomy is not planned by the multidisciplinary team due to anticipated poor clinical outcomes.Furthermore concurrence for palliative intent radiotherapy should be corroborated by 2 staff radiation oncologists.
  • Moderate to Severe Pain on Numerical Rating Score (Score 4 or higher).
  • Anticipated survival \< 12 months.
  • Patients with stage IVB with local disease extent as described in section 1 but systemic chemotherapy is not possible either due to deranged renal function or anticipated poor tolerance.

Age in the registry: 18 years to 75 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tata Memorial Hospital
Coordinator of this site? Confirm its status
MumbaiIndiaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.